Antiretroviral therapy coverage for PMTCT in Guatemala

Guatemala: Antiretroviral therapy coverage for PMTCT was 82.0% in 2023. ◆ Volatile

Latest (2023)
82.0%
Change on year
up 1.2%
World rank
38th
of 84 countries
All-time high
82.0%
in 2023
All-time low
2.0%
in 2000
Years of data
24
2000–2023

Antiretroviral therapy coverage for PMTCT in Guatemala, 2000–2023

0204060802000201120232000: 2 % of pregnant women living with HIV2001: 3 % of pregnant women living with HIV2002: 4 % of pregnant women living with HIV2003: 3 % of pregnant women living with HIV2004: 4 % of pregnant women living with HIV2005: 6 % of pregnant women living with HIV2006: 54 % of pregnant women living with HIV2007: 51 % of pregnant women living with HIV2008: 46 % of pregnant women living with HIV2009: 65 % of pregnant women living with HIV2010: 44 % of pregnant women living with HIV2011: 59 % of pregnant women living with HIV2012: 43 % of pregnant women living with HIV2013: 69 % of pregnant women living with HIV2014: 61 % of pregnant women living with HIV2015: 38 % of pregnant women living with HIV2016: 49 % of pregnant women living with HIV2017: 52 % of pregnant women living with HIV2018: 64 % of pregnant women living with HIV2019: 64 % of pregnant women living with HIV2020: 65 % of pregnant women living with HIV2021: 72 % of pregnant women living with HIV2022: 81 % of pregnant women living with HIV2023: 82 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

In 2023, antiretroviral therapy coverage for pmtct in Guatemala stood at 82.0%. That is the highest value across all 24 years on record.

Compared with earlier readings it is up 1.2% on the previous year and up 18.8% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Guatemala peaked at 82.0% in 2023 and was at its lowest, 2.0%, in 2000.

That places Guatemala 38th out of 84 countries with data for 2023, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Guatemala, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Guatemala, 2000 to 2023.
Year % of pregnant women living with HIV Change
2000 2.0%
2001 3.0% +50.0%
2002 4.0% +33.3%
2003 3.0% -25.0%
2004 4.0% +33.3%
2005 6.0% +50.0%
2006 54.0% +800.0%
2007 51.0% -5.6%
2008 46.0% -9.8%
2009 65.0% +41.3%
2010 44.0% -32.3%
2011 59.0% +34.1%
2012 43.0% -27.1%
2013 69.0% +60.5%
2014 61.0% -11.6%
2015 38.0% -37.7%
2016 49.0% +28.9%
2017 52.0% +6.1%
2018 64.0% +23.1%
2019 64.0% +0.0%
2020 65.0% +1.6%
2021 72.0% +10.8%
2022 81.0% +12.5%
2023 82.0% +1.2%

Guatemala compared with similar countries

  • Guatemala's 82.0% is above the median for upper middle income countries, which is 79.5%, 1.0× the median. (22 countries reporting)
  • Guatemala's 82.0% is above the median for Latin America & Caribbean, which is 68.0%, 1.2× the median. (15 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Guatemala changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2006 +800.0% 6.0% 54.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 23.8% 2.0% 65.0% 10
2010s 54.3% 38.0% 69.0% 10
2020s 75.0% 65.0% 82.0% 4

Countries ranked near Guatemala

  1. 35 Ecuador 85.0% compare
  2. 35 Vietnam 85.0% compare
  3. 37 Guyana 84.0% compare
  4. 38 Mozambique 82.0% compare
  5. 40 South Sudan 81.0% compare
  6. 41 Cape Verde 80.0% compare
  7. 41 Guinea 80.0% compare

See the full ranking of 99 places →

More health data for Guatemala

All data for Guatemala →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Guatemala?
Antiretroviral therapy coverage for pmtct in Guatemala was 82.0% in 2023, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Guatemala?
The highest recorded value was 82.0% in 2023.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Guatemala?
The lowest recorded value was 2.0% in 2000.
How does Guatemala rank for antiretroviral therapy coverage for pmtct?
Guatemala ranks 38th out of 84 countries with data for 2023.
Is antiretroviral therapy coverage for pmtct rising or falling in Guatemala?
Over the last ten years it is up 18.8%. The long-run trend across the full record is volatile.
Where does this Guatemala data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Guatemala. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/guatemala/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/guatemala/">Antiretroviral therapy coverage for PMTCT in Guatemala</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).